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Tightening the Epidermal Barrier 
with Atypical PKCs
Mitchell F. Denning1
The permeability barrier function of the epidermis is one of the most vital 
jobs performed by the skin; however, our understanding of the function and 
regulation of tight junctions in the epidermis remains limited. Helfrich et al. 
identify a key role for atypical protein kinase C (aPKC) activity, as a compo-
nent of the Par3–Par6 polarity complex, in epidermal barrier function.
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As the first line of defense against 
the outside world, the epidermis has 
an extensive arsenal of adhesive and 
sealing junctions that maintain physi-
cal integrity and act as a permeabil-
ity barrier against water loss, foreign 
microbes, and toxins. The assembly of 
adhesive and sealing junctions is tight-
ly linked to the stepwise epidermal 
differentiation program, which is also 
central to the barrier function of the 
epidermis via formation of the stratum 
corneum. Although our knowledge 
of the epidermal adhesive junctions 
(adherens junctions, desmosomes, 
hemi-desmosomes) is extensive, the 
existence and functional importance 
of the sealing tight junctions in the 
epidermis have only recently been 
appreciated (Furuse et al., 2002). Tight 
junctions are the occluding junctions 
found in epithelial cells and are com-
posed primarily of claudins, occlu-
din, and ZO proteins. However, the 
permeability barrier function of the 
epidermis was historically attributed 
primarily to the stratum corneum, with 
its covalently cross-linked proteins 
and lipids forming a waxy impedi-
ment to water movement. Indeed, 
proper formation of cornified enve-
lopes and extrusion of lamellar bodies 
are required to form the “bricks and 
mortar” of the stratum corneum (Elias, 
2005). This complex process requires 
that the highly coordinated kerati-
nocyte terminal differentiation pro-
gram be properly executed. Support 
for this concept includes engineered 
deletions of differentiation proteins in 
the mouse (transglutaminase I, KIf4), 
or common inactivating mutations 
in humans (filaggrin), both of which 
disrupt the epidermal barrier func-
tion (Matsuki et al., 1998; Segre et al., 
1999; Smith et al., 2006). However, as 
is highlighted below, the role of tight 
junctions in the permeability barrier 
function in the epidermis warrants 
equal consideration.
The article by Helfrich and col-
leagues (2007, this issue) expands 
our understanding of tight junctions 
in the epidermal barrier by character-
izing the localization of the polarity 
proteins Par3, Par6, and atypical pro-
tein kinase C (aPKCζ and aPKCι/λ) in 
mouse skin during wound healing and 
Ca2+-induced differentiation in vitro. 
The authors find an essential role for 
aPKC, especially active aPKCι/λ, in 
the establishment of the permeability 
barrier function in the granular layer, 
the site of tight junctions. These find-
ings have important implications for 
several cutaneous diseases with dis-
rupted barrier function.
The permeability barrier function 
of simple epithelia is entirely depen-
dent on tight junction integrity and is 
tightly linked to the formation of a tri-
partite polarity complex composed of 
aPKC, Par3, and Par6. Par6 functions 
as an adaptor protein linking aPKC 
and Cdc42 to Par3, and Par3 serves 
as a scaffolding protein recruiting the 
polarity complex to sites of tight junc-
tion assembly. The tight junctions in 
simple epithelial tissues perform two 
functions: (1) a barrier function to 
regulate paracellular transport, and 
(2) a fence function to divide or polar-
ize basolateral from apical membrane 
resident proteins and lipids. In the epi-
dermis, however, the polarization of 
junctional components is on a tissue 
level rather than on a cellular level, 
with tight junctions localized to the 
granular layer just beneath the stra-
tum corneum. Strong evidence for the 
requirement for tight junctions in epi-
dermal barrier function initially came 
from claudin-1-null mice (Furuse et 
al., 2002). These mice died shortly 
after birth and had impaired epider-
mal barrier function despite biochem-
ical and ultrastructurally normal stra-
tum corneum.
The study by Helfrich et al. (2007) 
found that in newborn mouse skin, 
aPKCι/λ partially colocalized with 
Par3 and Par6 in the granular layer at 
sites of cell–cell contact. Furthermore, 
during Ca2+-induced differentiation of 
keratinocytes in vitro, aPKC activity 
was necessary for the establishment of 
barrier function, and overexpression 
of aPKC accelerated and enhanced 
barrier function. Two highly homolo-
gous aPKC isoforms are expressed in 
the epidermis, aPKCζ and aPKCι/λ. As 
aPKCζ was not found in the granular 
layer, it was not directly implicated 
in normal epidermal barrier func-
tion; however, aPKCζ could com-
pensate for aPKCι/λ function when 
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overexpressed in vitro. Consistent 
with a critical physiological role for 
aPKCι/λ, mice null for aPKCι/λ are 
embryonic lethal and have cell-polar-
ity defects in ectodermal epithelia, 
whereas aPKCζ-null mice are viable 
despite having defects in NF-κB acti-
vation (Suzuki et al., 2003; Leitges et 
al., 2001). Taken together, these results 
indicate that aPKCζ and aPKCι/λ are 
capable of compensating for each 
other in polarity-associated barrier 
function but have different expression 
patterns and thus may perform sepa-
rate functions in vivo.
Atypical PKCs were also found to be 
redistributed during wound healing, a 
process that disrupts cell polarity and 
barrier function. Atypical PKCs were 
lost from the granular layer junctional 
complexes 5–7 days after wounding, 
and although Par3 did not redistribute, 
Par6 became diffusely localized in the 
cytoplasm. By day 5, Par6 returned 
to the granular layer. One intriguing 
feature of these localization studies 
was the strong nuclear and basement 
membrane zone staining seen for 
aPKC in newborn mouse skin and in 
the epidermis during re-epithelializa-
tion. This pattern was not seen with 
isoform-specific antibodies against 
either aPKCζ or aPKCι/λ, and this dif-
ferent localization may be due to con-
formation-specific epitopes or epitope 
masking. This variability in antibody 
staining is a major impediment to PKC 
localization studies and illustrates 
that caution is needed in interpreting 
PKC localization in tissues and cells. 
Apical localization of aPKCζ in basal 
keratinocytes of mouse epidermis was 
also described as part of the polarity 
complex regulating asymmetric cell 
division, suggesting that aPKCζ may 
be an endogenous regulator of cell 
polarity in basal keratinocytes (Lechler 
and Fuchs, 2005).
The authors also developed a novel 
assay for transepithelial resistance that 
measures permeability barrier func-
tion during Ca2+-induced keratinocyte 
differentiation in vitro. This system was 
validated by demonstration of recruit-
ment of the tight junction protein 
ZO-1 and occludin, along with active 
aPKC, to sites of cell–cell contact, as 
well as a time-dependent rise in trans-
epithelial resistance. This technical 
advance should find utility in a wide 
range of mutant keratinocytes with 
altered barrier function, especially in 
mouse models where embryonic or 
early postnatal lethality occurs, and in 
human diseases where barrier disrup-
tion is prominent (ichthyoses, psoria-
sis, atopic dermatitis). Keratinocytes 
can be cultured from patients or mice 
and induced to differentiate with Ca2+, 
and the molecular features of the bar-
rier defect studied in detail, with the 
use of this assay.
In addition to addressing impor-
tant questions about the role of the 
cell-polarity proteins Par3, Par6, and 
aPKC in epidermal barrier function, 
this study raises several new ques-
tions. Central among these is how 
aPKC activity promotes barrier func-
tion. Because aPKC enzyme activity 
was required for barrier function, the 
real question becomes: what are the 
important aPKC substrates that regu-
late tight junction function? In general, 
PKCs have broad substrate specificity 
when assayed in solution; however, 
cofactor availability and binding/scaf-
folding proteins tightly regulate PKC 
localization in cells and therefore 
restrict substrate availability. In this 
regard, Par6 may help localize aPKC 
to junctional complexes where yet-
to-be-identified junctional proteins 
can be phosphorylated. Although the 
inhibition of aPKC activity prevented 
the establishment of barrier func-
tion, it did not affect the recruitment 
of occludin to cell–cell contacts; this 
suggests that aPKC activity is required 
for the higher-order assembly and 
sealing functions of tight junctions. 
Indeed, only active aPKC extensively 
colocalized with ZO-1; total aPKC 
colocalization was much more limit-
ed. The identification of physiological 
aPKC substrates is a high-priority area 
in need of technical advances to move 
the field forward.
The link between epidermal dif-
ferentiation and barrier function may 
help explain the activation mechanism 
of aPKC in the granular layer. PKCζ 
and PKCι/λ are “atypical” in that they 
are not activated by the canonical dia-
cylglycerol or Ca2+ second messengers 
that activate classical and novel PKCs. 
Atypical PKCs are activated by a vari-
ety of other lipids, including cerami-
des and cholesterol sulfate, that are 
generated during granular layer differ-
entiation and are essential for the per-
meability barrier function (Lozano et 
al., 1994; Elias, 2005; Denning et al., 
1995). Thus the generation of these 
aPKC-activating ligands as a compo-
nent of the epidermal differentiation 
program may integrate aPKCι/λ acti-
vation with tight junction function 
in the granular layer. A complemen-
tary role of stratum corneum lipids 
in epidermal barrier may be an aPKC 
signaling function in addition to the 
well-described hydrophobic function 
as “mortar” (Elias, 2005).
Finally, the study by Helfrich et al. 
(2007) has implications for several 
skin diseases characterized by deregu-
lated epidermal permeability barrier. 
Common skin diseases such as pso-
riasis, ichthyosis vulgaris, atopic der-
matitis, and contact dermatitis are all 
characterized by defects in epidermal 
permeability barrier. Although the 
permeability defect in these diseases 
may be in part due to disruption of 
the normal stratum corneum forma-
tion, perturbations in epidermal polar-
ity and tight junction function should 
also be considered. In fact, the close 
association between two functions of 
epidermal differentiation in the stratum 
granulosum — generation of functional 
gap junctions and preparation of kerati-
nocytes for the formation of functional 
stratum corneum — makes these two 
barrier mechanisms functionally inter-
related and challenging to dissect.
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Soluble Fas Ligand: Is It a Critical 
Mediator of Toxic Epidermal 
Necrolysis and Stevens–Johnson 
Syndrome?
Junko Murata1 and Riichiro Abe1
Although soluble Fas ligand (sFasL) is an important candidate in toxic epi-
dermal necrolysis (TEN) and Stevens–Johnson syndrome (SJS), Stur and col-
leagues report that elevated sFasL has been detected in maculopapular 
rashes. In addition to sFasL, other factors, including predisposing genetic fac-
tors, should also be investigated to determine their precise pathogenesis in 
TEN and SJS.
Journal of Investigative Dermatology (2007) 127, 744–745. doi:10.1038/sj.jid.5700693
Toxic epidermal necrolysis (TEN) and 
Stevens–Johnson syndrome (SJS) are 
among the most severe cutaneous 
adverse reactions seen in humans. TEN 
and SJS are life-threatening diseases 
with a mortality rate approaching 25%. 
The main causes of these diseases are 
drug intake and, to a lesser extent, 
viral infection. In TEN and SJS patients’ 
epidermis, marked keratinocyte apop-
totic events are frequently observed. 
This keratinocyte apoptosis results in 
blister formation and widespread skin 
detachment. In contrast to TEN and 
SJS, maculopapular rashes (MPRs) are 
milder variants of cutaneous reac-
tions also due to drug allergy or viral 
infection. Occasional apoptotic kerati-
nocytes are sometimes observed histo-
logically in MPR epidermis.
So far, numerous possible mediators 
of keratinocyte apoptosis have been 
suggested, such as peripheral cytotoxic 
T cells, inflammatory cytokines, nitric 
oxide, granzyme B, and perforin. For 
example, Nassif et al. (2002) showed 
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that T lymphocytes present within TEN 
lesions may exhibit drug-specific cyto-
toxicity against autologous cells with-
out restimulation. However, although 
TEN and SJS lesional skin contained 
few inflammatory cells, there were no 
other convincing ways to explain how 
keratinocyte apoptosis might occur. 
In addition, tumor necrosis factor-α, 
a potent apoptotic mediator, has been 
suggested as a critical factor in TEN and 
SJS (Paquet et al., 1994). As increases 
in serum levels of tumor necrosis fac-
tor-α have been observed in various 
inflammatory diseases, it is unlikely 
that tumor necrosis factor-α alone is a 
specific mediator in TEN and SJS.
In 1998, Viard et al. (1998) reported 
that the activation of Fas through Fas 
ligand (FasL) is an important primary 
step leading to keratinocyte apoptosis 
in TEN. The generally held concept 
is that Fas and FasL are derived from 
keratinocytes, and that FasL expressed 
by keratinocytes causes keratinocyte 
apoptosis in TEN in either an auto-
crine or a paracrine fashion (Viard et 
al., 1998).
Conversely, we demonstrated that 
the levels of soluble FasL (sFasL) in 
patients’ sera were elevated in an ini-
tial phase and significantly declined 
between 3 and 6 days after the start of 
the disease course. We also showed 
that sFasL secretion from peripheral 
blood mononuclear cells could be 
induced after the causative drug stim-
ulation in vitro (Abe et al., 2003).
Clinically, there are some diffi-
culties in diagnosing TEN and SJS. 
Because patients sometimes show 
only maculopapular eruptions without 
any mucosal involvement in the early 
stage of disease, it is quite difficult to 
distinguish TEN and SJS from MPR. It 
is also difficult to determine from a 
patient’s clinical appearance and labo-
ratory data alone whether the disease 
is due to drug intake or viral infection.
Stur and colleagues (2007, this 
issue) show that sFasL levels were 
elevated in sera from SJS patients but 
were low in TEN patients. In addi-
tion to this result, they detected high 
sFasL levels in sera from MPR patients. 
In particular, sFasL serum levels were 
elevated in drug-induced MPR; how-
ever, no significant increase was 
